Another study by Mueller et al. reported that PPARγ is highly expressed in human primary and metastatic breast cancer, and ligand activation of this receptor in breast cancer cells causes extensive lipid accumulation, which results in a reduction in the growth rate and clonogenic capacity of tumor cells [55] [56]. Here, PPARG is linked to breast carcinoma.